Showing results (381-390 of 582) with videos related to
Sort By:
Pageof 59
Parkinsonism & Related Disorders|April 3, 2010
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystoniaDaniel Truong, Matthew Brodsky, Mark Lew, et al.Autoimmunity|September 17, 2010
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian AmericansPhilip R Deitiker, Minako Oshima, Joseph Jankovic, et al.Journal of the Neurological Sciences|December 17, 2003
Clinical gait and balance scale (GABS): validation and utilizationMadhavi Thomas, Joseph Jankovic, Monthaporn Suteerawattananon, et al.Journal of Neuroimmunology|November 15, 2011
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/BMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.Journal of Obsessive-Compulsive and Related Disorders|December 2, 2014
Progress in research on Tourette syndromeKevin J Black, Joseph Jankovic, Tamara Hershey, et al.Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.Parkinsonism & Related Disorders|February 15, 2011
Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulationAmy E Williams, Gladys Marina Arzola, Adriana M Strutt, et al.Movement Disorders Clinical Practice|August 27, 2024
Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta-AnalysisLuis Guilherme Ramanzini, Julia M Frare, Luís F M Camargo, et al.Pharmacological Research|May 9, 2025
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challengesZhi Dong Zhou, Lingxiao Yi, Karolina Popławska-Domaszewicz, et al.Journal of Neurochemistry|April 11, 2008
Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degenerationWen Zhu, Wenjie Xie, Tianhong Pan, et al.Pageof 59